Nue Life vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth platform for ketamine-assisted therapy for treatment-resistant depression and PTSD; oral ketamine with coaching at home; licensed physician oversight with published outcomes data.
About
Nue Life is a Miami-based mental health company that provides at-home ketamine-assisted therapy for treatment-resistant depression, anxiety, PTSD, and OCD through a telehealth model. The company pairs oral ketamine with therapeutic coaching and integration support to treat patients who have not responded to traditional antidepressants. Nue Life's model addresses barriers to ketamine therapy — geographic access to ketamine clinics and prohibitive out-of-pocket costs — by delivering treatment at home with telehealth physician oversight and licensed therapist integration support. The platform has treated thousands of patients with documented outcomes data and published case studies. Nue Life operates in the rapidly growing psychedelic-assisted therapy market, which has seen significant clinical validation for ketamine and clinical trial progress for MDMA and psilocybin. Founded in 2020, the company has raised funding to expand access to ketamine therapy while the regulatory environment for psychedelic medicine continues to evolve.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.